Ma L | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2464

Journal of Addiction Research & Therapy received 2464 citations as per google scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Ma L

Center for Neurobehavioral Research on Addiction, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, USA


Ma L is a versatile author and has contributed major research works in the field of Addiction Research and Therapy, psychology, and neurology. And has dedicated their major research contributions in the field of Addiction research, Substance-Related Disorders, Psychology, Neurology, Behavioural Science, etc.

Cardiovascular and Subjective Effects of the Novel Adenosine A2A ReceptorAntagonist SYN115 in Cocaine Dependent Individuals

A2A receptor antagonists have been proposed as therapeutic tools for dopaminergically-relevant diseases, including Parkinson's disease and substance dependence. The acute subjective and cardiovascular effects of a novel, selective adenosine A2A receptor antagonist (SYN115) were examined. Across an 8-hour experimental testing day, 22 nontreatment se... Read More»

Lane SD, Green CE, Steinberg JL, Ma L, Schmitz JM, Rathnayaka N, Rathnayaka N, Bandak SD, Ferre S and Moeller FG

Research Article: J Addict Res Ther 2012, S1-009

DOI: 10.4172/2155-6105.S1-009

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article